119 related articles for article (PubMed ID: 29403745)
1. Simple and sensitive determination of sparfloxacin in pharmaceuticals and biological samples by immunoassay.
Zeng HJ; Yang R; Liu B; Lei LF; Li JJ; Qu LB
J Pharm Anal; 2012 Jun; 2(3):214-219. PubMed ID: 29403745
[TBL] [Abstract][Full Text] [Related]
2. Improvement and validation of an HPLC method for examining the effects of the MDR1 gene polymorphism on sparfloxacin pharmacokinetics.
Cho HY; Park SA; Lee YB
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Apr; 834(1-2):84-92. PubMed ID: 16530028
[TBL] [Abstract][Full Text] [Related]
3. Quantitative determination of erlotinib in human serum using competitive enzyme-linked immunosorbent assay.
Yamamoto Y; Saita T; Yamamoto Y; Shin M
J Pharm Anal; 2018 Apr; 8(2):119-123. PubMed ID: 29736298
[TBL] [Abstract][Full Text] [Related]
4. Determination of sparfloxacin in plasma and urine by a simple and rapid liquid chromatographic method.
Kamberi M; Kamberi P; Hajime N; Uemura N; Nakamura K; Nakano S
Ther Drug Monit; 1999 Aug; 21(4):411-5. PubMed ID: 10442694
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of pefloxacin serum concentrations in intensive care unit patients: comparison of a new immunoassay with high-performance liquid chromatography.
Lacarelle B; Le Guellec C; Morel A; Albanese J; Alazia M; Ballereau M; Llurens M; Bruno R; Francois G; Durand A
Ther Drug Monit; 1994 Apr; 16(2):209-13. PubMed ID: 8009571
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of sparfloxacin in the serum and vitreous humor of rabbits: physicochemical properties that regulate penetration of quinolone antimicrobials.
Liu W; Liu QF; Perkins R; Drusano G; Louie A; Madu A; Mian U; Mayers M; Miller MH
Antimicrob Agents Chemother; 1998 Jun; 42(6):1417-23. PubMed ID: 9624487
[TBL] [Abstract][Full Text] [Related]
7. ELISA for the quantification of pilsicainide.
Saita T; Fujito H; Mori M
Biol Pharm Bull; 2001 Oct; 24(10):1113-6. PubMed ID: 11642313
[TBL] [Abstract][Full Text] [Related]
8. High performance thin-layer chromatographic method for the determination of sparfloxacin in human plasma and its use in pharmacokinetic studies.
Mody VD; Pandya KK; Satia MC; Modi IA; Modi RI; Gandhi TP
J Pharm Biomed Anal; 1998 Apr; 16(8):1289-94. PubMed ID: 9777602
[TBL] [Abstract][Full Text] [Related]
9. Effect of fenbufen on the pharmacokinetics of sparfloxacin in rats.
Naora K; Katagiri Y; Iwamoto K; Tanaka K; Yamaguchi T; Sekine Y
J Antimicrob Chemother; 1992 Nov; 30(5):673-83. PubMed ID: 1337351
[TBL] [Abstract][Full Text] [Related]
10. Development of an enzyme-linked immunosorbent assay for serum 11-dehydrocorticosterone in rat and mouse.
Tagawa N; Ikariko N; Fukumura K; Kobayashi Y
Biol Pharm Bull; 2007 Mar; 30(3):403-9. PubMed ID: 17329828
[TBL] [Abstract][Full Text] [Related]
11. Quantitative determination of sparfloxacin in rat plasma by liquid chromatography/tandem mass spectrometry.
Noh K; Kwon KI; Jeong TC; Kang W
Biomed Chromatogr; 2010 Nov; 24(11):1199-202. PubMed ID: 20737450
[TBL] [Abstract][Full Text] [Related]
12. Development of enzyme-linked immunosorbent assay for therapeutic drug monitoring of mexiletine.
Saita T; Fujito H; Mori M
Biol Pharm Bull; 2003 Jun; 26(6):761-5. PubMed ID: 12808282
[TBL] [Abstract][Full Text] [Related]
13. Development of a competitive enzyme-linked immunosorbent assay for therapeutic drug monitoring of afatinib.
Sogawa R; Saita T; Yamamoto Y; Kimura S; Narisawa Y; Kimura S; Shin M
J Pharm Anal; 2019 Feb; 9(1):49-54. PubMed ID: 30740257
[TBL] [Abstract][Full Text] [Related]
14. Biotin-avidin amplified enzyme-linked immunosorbent assay for determination of isoflavone daidzein.
He JT; Shi ZH; Yan J; Zhao MP; Guo ZQ; Chang WB
Talanta; 2005 Feb; 65(3):621-6. PubMed ID: 18969844
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic interaction of sparfloxacin and digoxin.
Johnson RD; Dorr MB; Hunt TL; Conway S; Talbot GH
Clin Ther; 1999 Feb; 21(2):368-79. PubMed ID: 10211539
[TBL] [Abstract][Full Text] [Related]
16. Quantification of sparfloxacin in pharmaceutical dosages and biological samples.
Shah J; Jan MR; Khan I; Khan MN
Pak J Pharm Sci; 2012 Oct; 25(4):823-9. PubMed ID: 23010000
[TBL] [Abstract][Full Text] [Related]
17. Development of a sandwich enzyme-linked immunosorbent assay for the determination of human heart type fatty acid-binding protein in plasma and urine by using two different monoclonal antibodies specific for human heart fatty acid-binding protein.
Ohkaru Y; Asayama K; Ishii H; Nishimura S; Sunahara N; Tanaka T; Kawamura K
J Immunol Methods; 1995 Jan; 178(1):99-111. PubMed ID: 7829870
[TBL] [Abstract][Full Text] [Related]
18. Sandwich enzyme-linked immunosorbent assay for naringin.
Qu H; Wang X; Qu B; Kong H; Zhang Y; Shan W; Cheng J; Wang Q; Zhao Y
Anal Chim Acta; 2016 Jan; 903():149-55. PubMed ID: 26709308
[TBL] [Abstract][Full Text] [Related]
19. Development of a specific and sensitive enzyme-linked immunosorbent assay for the quantification of imatinib.
Saita T; Shin M; Fujito H
Biol Pharm Bull; 2013; 36(12):1964-8. PubMed ID: 24292055
[TBL] [Abstract][Full Text] [Related]
20. Development of a highly sensitive and specific enzyme-linked immunosorbent assay (ELISA) for the detection of phenylethanolamine A in tissue and feed samples and confirmed by liquid chromatography tandem mass spectrometry (LC-MS/MS).
Cao B; He G; Yang H; Chang H; Li S; Deng A
Talanta; 2013 Oct; 115():624-30. PubMed ID: 24054641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
